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www.elsevier.com/locate/ygenoGenomics 88 (200EditorialWhenever I meet people for the first time, the conversation
inevitably turns to what is in all likelihood one of the most asked
questions in human interactions: “What do you do?” My
answer, at least to scientists, is “genomics.” In many ways this
captures both the spirit and essence of what I think of on a daily
basis better than any other single term I know.
But what is genomics? Defining the term is a challenge in
large part because the field itself—if there is a single field—
continues to evolve rapidly. We have gone far beyond the early
days when we as a community dreamed of mapping or
sequencing the human genome and the genomes of a small
number of model organisms. Today large numbers of species
have been mapped and sequenced, and counting them is almost
a fruitless exercise because any tally would be out of date before
it appeared in print. The success of genomics as a field is
reflected in the fact that its early techniques have faded into the
“standard arsenal” of techniques we use to study problems of
biological significance. The number of organisms that have
been sequenced is dwarfed by any count of those analyzed using
EST sequencing, SAGE analysis, mapping of BAC clones, and
low-coverage shotgun sequencing (and the ubiquity of these
techniques is evident because I no longer need to define any of
the acronyms I’ve used).
But genomics has gone far beyond the initial goals of
generatingDNA sequence and producing a catalog of genes. The
transforming event of the Human Genome Project was not the
completion of the current reference sequence. Rather, genomics
has fundamentally changed the way we think about biological
problems and has delivered new technologies that allow us to
take a holistic view of how organisms evolve, respond, adapt,
and develop. DNA microarrays, proteomics, metabolomics,
whole genome SNP genotyping, and a host of computational
tools have altered the way in which we as scientists approach a
wide range of basic, clinical, and translational investigations.
In 1987, the journal Genomics was founded to capture the
spirit of this emerging field. The creation of the journal was in
large part due to the foresight of Victor McKusick and Frank
Riddle, two giants in the world of genetics. Their reputations, as
well as their leadership in creating a journal where genomic
studies could be published, gave the field a level of legitimacy
that had not previously existed and the journal itself provided a
definitive name for the new science that was being created. Over
the years the journal has been stewarded by scientists of0888-7543/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
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recently Mark Boguski. The list of associate editors, Editorial
Board members, and Advisory Board members reads like a
who’s who in the field and includes many members of various
National Academies and individuals whose names are, I am
sure, uttered yearly in discussions at the Nobel Foundation.
A few years ago I was asked to join the Editorial Board and
gladly accepted the honor. I have always believed that part of
our role as scientists is to contribute actively to stewarding the
development of our craft by ensuring that science of the highest
quality is published in a form that will make the information
available in a way that will accelerate discovery. It is a
responsibility I take very seriously and since joining the board,
it has been my pleasure to handle the many papers that I thought
were excellent applications of genomic approaches to the
discovery of new biological phenomena. I also had the pleasure
of working with the other members of the Editorial Board and,
under Mark Boguski’s leadership, we worked together to
continue to improve the journal, the quality of the science that it
reported, and its impact in the scientific community.
A few months ago I was approached by Mark Boguski and
asked if I might be willing to take over editorial oversight of the
journal. Needless to say, the invitation was an honor, but I also
knew that accepting the invitation would present a number of
challenges. After many long discussions with Mark, I agreed to
accept his invitation.
As I assume the position, I think it is important to say a few
words about Mark Boguski. Both professionally and personally,
there are few people I admire more. When I began my career in
genomics in 1992, Mark was already a recognized leader in the
field. He was one of the pioneers in the application of
computational methods in the study of biological problems
and had the foresight to see that creating genomic databases had
value far beyond “stamp collecting.” His work over the years
has demonstrated that genome-scale data, analyzed using
sophisticated computational methods and filtered through
keen biological insight, can drive discovery and innovation.
Mark has also been a leader in communicating science and
genomics both to the general public and to the scientific
community. It is this combination of skills and abilities that has
both propelled him to his position as an international leader in
genomics and made him such an outstanding editor in chief. I
truly stand on the shoulders of giants.
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Mark’s successes. I have been in discussion with the editorial
staff about how I think we can best do this, and you should
begin to see additional positive changes in the way the journal
makes the science available to the community, by offering
authors the option to sponsor articles to make them freely
available to nonsubscribers and by publishing more reviews and
minireviews in areas that I hope will be of broad interest. I also
think it is important to continue to expand the scope of what the
journal publishes because “genomic approaches” now include
far more than a focus on genes or genome sequencing but rather
represent a holistic way of thinking about problems in the
biological sciences in order to drive new understanding.
Of course, the continued success of the journal will not be
possible without the work of our Editorial Board and the large
number of referees who work with the Board members to ensure
the quality of the science that is published. I also think it isimportant to thank them for their dedication to this important
work, for the time they invest, and for their continued support. It
will be a pleasure and an honor to continue working with them.
Most importantly, the success of this or any journal is driven
by the quality of the science it publishes. This is obviously the
result of the hard work of thousands of people around the world
whose dedication to their craft and to the advancement of
human understanding through sharing their discoveries is what
makes scientific research such a rewarding experience. I hope
that as editor in chief I, and the journal, can continue to serve
your needs. It is my sincere hope that Genomics, both the field
and the journal, continue to grow and flourish.
And if I happen to meet you for the first time, and the
question of what you do invariably is asked, nothing would
please me more than to have you answer, “genomics.”
John Quackenbush
